KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Long-Term Deferred Tax (2016)

Historic Long-Term Deferred Tax for Neogenomics (NEO) over the last 3 years, with Q4 2016 value amounting to $6.5 million.

  • Neogenomics' Long-Term Deferred Tax rose 12005.62% to $6.5 million in Q4 2016 from the same period last year, while for Dec 2016 it was $6.5 million, marking a year-over-year increase of 12005.62%. This contributed to the annual value of $6.5 million for FY2016, which is 12005.62% up from last year.
  • As of Q4 2016, Neogenomics' Long-Term Deferred Tax stood at $6.5 million, which was up 12005.62% from -$32.4 million recorded in Q4 2015.
  • Neogenomics' Long-Term Deferred Tax's 5-year high stood at $6.5 million during Q4 2016, with a 5-year trough of -$32.4 million in Q4 2015.
  • For the 3-year period, Neogenomics' Long-Term Deferred Tax averaged around -$8.5 million, with its median value being $320000.0 (2014).
  • Per our database at Business Quant, Neogenomics' Long-Term Deferred Tax crashed by 1022781.25% in 2015 and then skyrocketed by 12005.62% in 2016.
  • Neogenomics' Long-Term Deferred Tax (Quarter) stood at $320000.0 in 2014, then crashed by 10227.81% to -$32.4 million in 2015, then soared by 120.06% to $6.5 million in 2016.
  • Its Long-Term Deferred Tax was $6.5 million in Q4 2016, compared to -$32.4 million in Q4 2015 and $320000.0 in Q4 2014.